๐“œ๐“ช๐“ป๐“ฒ๐“ช๐“ท ๐“ฅ๐“ช๐“ต๐“ญ๐“ฒ๐“ฟ๐“ฒ๐“ช ๐Ÿงฌ๐Ÿ’–โ€” HTGAA Spring 2026

cover image cover image

About me

Hi! My name is Marian I completed my undergraduate degree in Biotechnological Engineering from UCSM in Peru. I have a strong interest in bees, beekeeping, and meliponiculture ๐Ÿ, fun fact I’m highly allergic to bee stings. Also, I love molecular biology ๐Ÿงฌ and the early study and detection of neurological diseases ๐Ÿง . My goal is to pursue postgraduate studies in Synthetic Biology abroad.

Contact info

Homework

Labs

Projects

Subsections of ๐“œ๐“ช๐“ป๐“ฒ๐“ช๐“ท ๐“ฅ๐“ช๐“ต๐“ญ๐“ฒ๐“ฟ๐“ฒ๐“ช ๐Ÿงฌ๐Ÿ’–โ€” HTGAA Spring 2026

Homework

Weekly homework submissions:

Subsections of Homework

Week 1: Principles and Practices ๐Ÿ”ฌ

cover image cover image

cover image cover image

cover image cover image

Week 2 HW: DNA read / write /edit ๐Ÿงฌ

Part I: Benchling & In-silico Gel Art

I created my benchling account and imported the sequence GEN BANK CODE:J02459.1 from the NCBI website. I added the sequence to my benchling proyect folder.

Then I simulated Restriction Enzyme Digestion with adding the following enzymes and then cutted the DNA in the restricted places

Part III: DNA Design Challenge

3.1. Choose your protein:

PROTEIN: Phospholipase A2 Apis mellifera - PA2 APIME

I’ve chosen phospholipase A2 originating from Apis mellifera due to being a key enzymatic factor of honeybee venom and for their study as potential neuroprotective and immunomodulatory agents. Bee venom phospholipase A2 has been reported as having properties that reduce neuroinflammation and protect dopaminergic neurons in animal models of Parkinson’s Disease.

I obtained the protein sequence from Uniprot

sp|P00630|PA2_APIME Phospholipase A2 OS=Apis mellifera OX=7460 PE=1 SV=3 MQVVLGSLFLLLLSTSHGWQIRDRIGDNELEERIIYPGTLWCGHGNKSSGPNELGRFKHT DACCRTHDMCPDVMSAGESKHGLTNTASHTRLSCDCDDKFYDCLKNSADTISSYFVGKMY FNLIDTKCYKLEHPVTGCGERTEGRCLHYTVDKSKPKVYQWFDLRKY

3.2. Reverse Translate: Protein (amino acid) sequence to DNA (nucleotide) sequence.

Using a reverse translation tool, I converted my amino acid sequence into a nucleotide sequence based on the standard genetic code. Because multiple codons can encode the same amino acid, the resulting sequence represents one of several possible valid sequences that could produce this protein. I obtained the nucleotides using the following tool available on internet: https://www.bioinformatics.org/sms2/rev_trans.html

reverse translation of sample sequence to a 501 base sequence of most likely codons. atgcaggtggtgctgggcagcctgtttctgctgctgctgagcaccagccatggctggcag attcgcgatcgcattggcgataacgaactggaagaacgcattatttatccgggcaccctg tggtgcggccatggcaacaaaagcagcggcccgaacgaactgggccgctttaaacatacc gatgcgtgctgccgcacccatgatatgtgcccggatgtgatgagcgcgggcgaaagcaaa catggcctgaccaacaccgcgagccatacccgcctgagctgcgattgcgatgataaattt tatgattgcctgaaaaacagcgcggataccattagcagctattttgtgggcaaaatgtat tttaacctgattgataccaaatgctataaactggaacatccggtgaccggctgcggcgaa cgcaccgaaggccgctgcctgcattataccgtggataaaagcaaaccgaaagtgtatcag tggtttgatctgcgcaaatat

3.3. Codon optimization.

I need to optimize my codons so that the chosen organism can express them accurately.

Chosen organism: E. coli

I optimized my sequence for expression in E. coli K12 usign the following tool: JCat I realized that the Codon Adaptation Index improve from a value of 0.58 to 1.0, indicating optimal codon usage for the host organism. The GC content of the optimized sequence (51.3%) is consistent with the genomic GC content of E. coli.

Translation of the optimized sequence confirmed that the amino acid sequence remained unchanged because it matches with the previous protein equence I obtained in part 3.1 from Uniprot.

3.4. You have a sequence! Now what?

Using an expression vector, the recombinant DNA sequence (which has an optimized codon) can be cloned into a host organism. The host cell transcribes this new DNA sequence into mRNA, which is then translated into protein. Protein production can be done using either cell-based or cell-free expression systems; however, toxic proteins should generally be produced using a cell-free expression system to avoid harming the host organism.

Part V: DNA Read/Write/Edit

5.1 DNA Read

(i) What DNA would you want to sequence (e.g., read) and why? I want to analyze eDNA (environmental DNA for short) from the beesโ€™ hives for tracking viruses and monitoring the local flora. It’s important to identify the bacterial/fungal populations and the presence of viruses within the hives to combat Colony Collapse Disorder and to maintain healthy populations of pollinators capable of producing the Phospholipase A2 Iโ€™m researching. (ii) What technology or technologies would you use to perform sequencing on your DNA and why? I would use Oxford Nanopore Sequencing because of its portability and ability to produce long reads, which are essential for identifying complex microbial communities in the field *GENERATION: Third generation sequencing system allows sequencing of individual DNA molecules without PCR amplification. *INPUT AND PREPARATION: Input consists of high molecular weight genomic DNA. Library preparation requires breaking genomic DNA into smaller pieces (if needed) and then inserting a sequencing adapter at both ends of each piece. The sequencing adapter contains a “motor-protein” that controls the passage of the DNA through the nanopore. *ESSENTIAL STEPS AND BASE CALLING: During sequencing, the DNA molecule passes through a protein nanopore in an electrically charged membrane. Movement of the DNA through the nanopore causes electrical current changes. The base calling algorithm uses a neural network to translate the electrical current changes into a nucleotide A, T, G or C. *OUTPUT: The final output is a FASTQ file for the output of a long read sequence and quality score.

5.2 DNA Write

(i) What DNA would you want to synthesize (e.g., write) and why? I would want to synthesize the expression cassette for the honeybee Phospholipase A2 (PA2_APIME) that I designed in Part 4. The goal is to produce this protein in a cell-free system to study its potential neuroprotective properties for Parkinsonโ€™s Disease research without the toxicity issues associated with cellular expression. (ii) What technology or technologies would you use to perform this DNA synthesis and why? I would use Silicon-based DNA synthesis (Twist Bioscience). This technology allows for high-throughput, accurate synthesis of gene fragments and clonal genes at a significantly lower cost than traditional methods *ESSENTIAL STEPS: The process starts with a silicon chip where thousands of oligonucleotides are synthesized in parallel using a phosphoramidite-based chemical process. These small fragments are then harvested, assembled into longer genes (using methods like Gibson Assembly), and verified for accuracy through NGS *LIMITATIONS: While highly scalable, limitations include complexity constraints; sequences with high GC content or long repetitive regions are difficult to synthesize accurately and may take longer to produce or fail the “complexity check.

5.3 DNA Edit

(i) What DNA would you want to edit and why? I would like to edit the genome of E. coli host strains to improve their tolerance to the expression of toxic proteins like Phospholipase A2. By editing specific metabolic pathways or membrane transporters, we could create “super-strains” optimized for the bioproduction of therapeutic venom proteins (ii) What technology or technologies would you use to perform these DNA edits and why? I would use CRISPR/Cas9 because of its high precision, ease of programming via a guide RNA (gRNA), and ability to perform multiple edits simultaneously (multiplexing) *HOW IT EDITS: The Cas9 nuclease acts like molecular scissors. Directed by a gRNA, it binds to a specific target sequence and creates a double-strand break (DSB). The cell then repairs this break through Non-Homologous End Joining (NHEJ) to knock out a gene, or Homology-Directed Repair (HDR) to insert a specific sequence if a template is provided. *PREPARATION AND INPUT: The required inputs include the Cas9 enzyme (or a plasmid encoding it), a custom-designed gRNA targeting the site of interest, and a repair template (DNA) if a specific insertion or change is desired *LIMITATIONS: The main limitations are off-target effects (unintended edits at similar sequences) and varying efficiency depending on the cell type and the specific genomic location being targeted.

Week 3: Lab automation ๐Ÿค–

The final result! My Lumpy space princess made with and Opentrons!

Week 4 HW: Protein design Part I ๐Ÿ’ปโฃ๏ธ

Week 5 HW: Protein design Part II๐Ÿ’ปโฃ๏ธ

Week 6 HW: Genetic circuits Part I ๐Ÿช›

Week 7 HW: Genetic circuits Part II๐Ÿ”ง

Week 9 HW: ห™โ‹†โœฎ Cell-Free-Systems โœฎโ‹†ห™

Week 10 HW: Imaging and measurement๐Ÿ’•

Week 11 HW: Bioproduction and Cloud Labs โ˜๏ธ

Subsections of Labs

Week 1 Lab: Pipetting

cover image cover image

Projects

Final projects:

  • SECTION 1: ABSTRACT Project Title: BeeO-Tech: A Synthetic Biology Biosensor for Real-Time Propolis Quality and Standardization Abstract: Propolis is a complex resinous matrix collected by honeybees (Apis mellifera) to protect their hives as a natural antiseptic. A significant portion of its medicinal potency directly depends on its specific flavonoid content. However, ensuring quality control is a critical challenge for regional beekeepers, as propolis composition varies drastically between harvests due to geographical factors and handling. In rural areas of Peru, producers lack access to expensive, centralized laboratory analysis, forcing them to sell uncertified products at low prices and excluding them from global markets. BeeO-Tech addresses this barrier by proposing an easy-to-use biological device designed to allow beekeepers to validate their productโ€™s value at a molecular level.

Subsections of Projects

Individual Final Project ๐Ÿ

SECTION 1: ABSTRACT

Project Title: BeeO-Tech: A Synthetic Biology Biosensor for Real-Time Propolis Quality and Standardization
Abstract: Propolis is a complex resinous matrix collected by honeybees (Apis mellifera) to protect their hives as a natural antiseptic. A significant portion of its medicinal potency directly depends on its specific flavonoid content. However, ensuring quality control is a critical challenge for regional beekeepers, as propolis composition varies drastically between harvests due to geographical factors and handling. In rural areas of Peru, producers lack access to expensive, centralized laboratory analysis, forcing them to sell uncertified products at low prices and excluding them from global markets. BeeO-Tech addresses this barrier by proposing an easy-to-use biological device designed to allow beekeepers to validate their product’s value at a molecular level.

The overall objective of this theoretical framework is to design a whole-cell and cell-free genetic circuit capable of detecting flavonoids in propolis and producing a proportional green fluorescent protein (sfGFP) signal. We hypothesize that the transcriptional repressor TtgR can serve as the central control lock by binding physically to the PttgA promoter to keep the system strictly “OFF” in the absence of target molecules. Upon future exposure to propolis, specific flavonoids would act as a key that releases TtgR, switching the circuit “ON” to express sfGFP. This project combines Benchling DNA design, Asimov Kernel kinetic simulations, molecular docking, and a future plan for lyophilization (freeze-drying) of cell-free molecular machinery to establish a portable, low-cost bio-certification standard.


SECTION 2: PROJECT AIMS

  • Aim 1: Experimental Aim (this project): The first aim of my final project is to design the digital architecture of a flavonoid-responsive biosensor using the TtgR repressor protein and the PttgA promoter controlling a sfGFP reporter gene inside Benchling, ensuring a tight genetic lock with zero simulated basal expression.
  • Aim 2: Development Aim: The next step will be to test the circuit’s kinetic logic using the Asimov Kernel platform to simulate dose-dependent fluorescence induction curves, while simultaneously utilizing computational molecular docking tools to predict the specific binding affinities between the TtgR protein and key target flavonoids found natively in Peruvian propolis.
  • Aim 3: Visionary Aim: The long-term vision of BeeO-Tech is to transition this circuit into a stable, cell-free system by theoretically extracting the transcriptional molecular machinery and utilizing lyophilization (freeze-drying) to embed it onto a paper-based matrix. Fully realized, this portable, non-living device would integrate with a companion digital smartphone application to quantify fluorescence readouts instantly, providing rural beekeepers with an autonomous, on-site quality grading scale without requiring refrigeration or laboratory containment.

SECTION 3: BACKGROUND

Background and Literature Context

Propolis possesses vast pharmaceutical potential due to its antimicrobial and antioxidant properties, which are strongly correlated with its polyphenol and flavonoid concentrations. Unfortunately, small-scale apicultural communities cannot afford traditional analytic chromatography (HPLC) to standardize their extracts. Synthetic biology offers an elegant solution by repurposing natural bacterial defense mechanisms. In nature, environmental bacteria utilize specialized transcriptional regulators to detect and efflux toxic plant aromatic compounds. By hijacking these specific regulatory blocks, we can design custom genetic circuits that turn chemical detection into an optical signal, translating complex natural chemistry into clear biological data.

Peer-Reviewed Citations Summary

  1. Terรกn, W., et al. (2003). Efflux pump regulation by TtgR. This foundational research characterizes the TtgR repressor protein from Pseudomonas putida, proving its highly specific structural capacity to bind a wide variety of plant antimicrobial flavonoids and monoterpenes, which makes it an ideal sensory candidate for natural propolis matrices.
  2. Alguel, Y., et al. (2007). Crystal structure of TtgR bound to complex ligands. The authors detail the crystallographic structure of the TtgR lock mechanism, demonstrating how ligand binding induces a conformational change that reduces its affinity for DNA, allowing us to model accurate molecular docking simulations with Peruvian flavonoids.

Novelty and Innovation

The innovation of BeeO-Tech lies in repurposing the TtgR and PttgA repressor matrix, traditionally studied for antibiotic efflux pump resistance, as a quantitative quality-control tool for artisanal apiculture. It bridges complex computational biophysicsโ€”like molecular docking of regional natural productsโ€”with accessible genetic circuits. By designing this system specifically to eliminate leaky basal expression in silico, the project introduces a highly reliable binary-to-linear logic framework to natural product screening. Finally, the proposed future shift to a lyophilized, cell-free matrix expands the boundaries of synthetic biology by making it deployable without specialized laboratory containment.

Significance and Impact

This project aims to solve the real-world problem of market exclusion and low-income traps faced by rural Peruvian beekeepers due to uncertified products. Proposing an affordable molecular validation tool addresses a massive socioeconomic barrier, allowing fair-trade agricultural sectors to confidently access international pharmaceutical markets in the future. Societally, it empowers biodiversity conservation by increasing the economic value of local bee hives and native flora ecosystems. Scientifically, it advances the theoretical understanding of TtgR ligand plasticity when interacting with raw, complex multi-compound organic mixtures. Ultimately, if these aims are achieved, it will shift the paradigm of natural medicine verification from expensive centralized facilities to instant, field-based digital readouts.

Ethical Implications

The BeeO-Tech project actively applies the ethical principles of beneficence and justice. Beneficence is achieved by proposing a platform designed to directly enhance the economic autonomy of underserved agricultural workers while providing consumers with verified, standardized therapeutic bioproducts. The project champions justice by democratizing high-tech synthetic biology concepts, ensuring that advanced scientific capabilities are not restricted to wealthy metropolitan institutions but are actively tailored to solve pressing challenges for rural, resource-limited communities in developing nations.

To satisfy the principle of non-maleficence, the project framework carefully mitigates ecological and safety concerns regarding the future field use of engineered organisms. Our primary proposed action to avoid GMO contamination is transitioning the biological circuit into a completely non-living, lyophilized cell-free system on paper test strips. A potential unintended consequence or uncertainty could arise from variations in environmental temperature affecting the future test’s enzyme kinetics, which could lead to false quality evaluations. To counter this, an alternative strategy includes integrating a digital calibration reference curve inside the companion smartphone application, allowing the software to normalize the visual data against local ambient conditions to ensure safety and accuracy.


SECTION 4: EXPERIMENTAL DESIGN, TECHNIQUES, TOOLS, AND TECHNOLOGY

Proposed Experimental Plan and Timeline

  1. Week 1: Search literature databases to gather complete sequence variants of the Pseudomonas TtgR repressor and its corresponding PttgA promoter region.
  2. Week 1: Download 3D structural files (.PDB) of the TtgR protein dimer from the Protein Data Bank for computational analysis.
  3. Week 2: Open Benchling to map out the digital architecture of the composite plasmid expression vector.
  4. Week 2: Model the cloning of a constitutive promoter sequence upstream of the TtgR open reading frame to ensure constant repressor production.
  5. Week 3: Design the downstream sensor component by placing the sfGFP reporter gene under the direct control of the PttgA operator in silico.
  6. Week 3: Perform sequence alignment checks to verify that no unwanted restriction sites interfere with the digital plasmid backbone.
  7. Week 4: Export the final GenBank file and input the circuit layout into the Asimov Kernel simulator workspace.
  8. Week 4: Execute ordinary differential equation (ODE) models to simulate whether steady-state TtgR levels successfully keep sfGFP expression at zero.
  9. Week 5: Gather chemical structures of predominant Peruvian propolis flavonoids (e.g., galangin, quercetin) from PubChem.
  10. Week 5: Set up molecular docking simulations using Autodock Vina to calculate predicted binding energies ($\Delta G$) between TtgR and regional flavonoids.
  11. Week 6: Expected Outcome 1: Theoretical identification of specific flavonoids that act as optimal structural keys to unlock the TtgR repressor pocket.
  12. Week 6: Design custom primers in Benchling to outline future physical assembly loops via theoretical PCR reactions.
  13. Week 7: Formulate computational liquid handling automation commands via Python scripts tailored for a potential Opentrons OT-2 robot setup.
  14. Week 7: Expected Outcome 2: Simulated induction kinetics showing a crisp sigmoidal curve transitioning from OFF to ON as flavonoid concentrations increase.
  15. Week 8: Complete the biosecurity review checklist to ensure the designed sequence complies with theoretical manufacturing regulations.
  16. Week 8: Compile all computational notebooks, docking logs, and plasmid maps into an open-source public repository for community review.

Techniques Checklist

  • Bioethical Considerations
  • DNA Construct Design
  • Databases (e.g., GenBank, NCBI)
  • Use of Asimov Kernel
  • Use of Benchling
  • Chassis Selection (e.g., DH5alpha)
  • Cell-Free Reactions
  • Freeze-Dried Cell-Free Systems

Techniques Expansion

I will utilize DNA Construct Design inside Benchling to build the precise digital layout of the TtgR and PttgA biosensor, ensuring the repressor and reporter genes are correctly balanced in my model. Additionally, I plan to leverage Freeze-Dried Cell-Free Systems concepts to outline the future transition of my computational genetic design into a physical, non-living testing device. This proposed technique involves modeling how the transcription machinery extracted from cells would react to lyophilization techniques to preserve the molecular components on a paper substrate, allowing safe, portable field deployment without requiring laboratory containment.


SECTION 5: RESULTS & QUANTITATIVE EXPECTATIONS

Validation Selection

I chose to validate the In-Silico Logic Circuit Design, Kinetic Simulation, and Computational Molecular Docking Affinity of the TtgR-based biosensor. This virtual validation proves that the genetic lock handles target interactions correctly and transitions states predictably under simulated flavonoid triggers.

Detailed Validation Protocol

  1. Construct the TtgR-repressed sfGFP plasmid map inside the Benchling workspace.
  2. Export the annotated sequence map as a standardized GenBank file format.
  3. Load the expression parameters into a Python-based Asimov Kernel simulation loop.
  4. Run kinetic models simulating steady-state repressor binding to the PttgA site to confirm the theoretical baseline remains at zero.
  5. Import the TtgR crystal structure (.PDB) and regional flavonoid structures (.SDF) into a virtual molecular docking environment.
  6. Execute docking grids to calculate the theoretical binding affinity scores (kcal/mol) of the flavonoids within the TtgR binding pocket.
  7. Correlate simulated flavonoid rehydration volumes (0 to 100 $\mu$M) to graph the predicted concentration-to-fluorescence induction curve.

Synthetic Biology Techniques Utilized

I applied DNA Construct Design principles to digitally orchestrate the alignment of regulatory promoters and fluorescent output genes into a functional operon framework. I utilized online biological Databases to pull verified sequence files and 3D protein structures essential for structural modeling. Furthermore, Models and Notebooks were employed to map out ordinary differential equations governing simulated cell-free transcription rates under the Asimov Kernel guidelines. Lastly, Bioethical Considerations were integrated by choosing a non-living lyophilized matrix for my future deployment model, theoretically eliminating any risk of environmental GMO proliferation during practical field testing.

Data Presentation and Analysis

The validation data is presented as a simulated induction graph comparing flavonoid concentration against Relative Fluorescence Units (RFU) within a virtual cell-free system. The Asimov simulation verified that while TtgR is modeled to actively block the promoter, baseline leakiness remains at zero; upon simulated introduction of the target ligand, the system undergoes a sharp sigmoidal transition, reaching full activation at a threshold concentration that matches realistic ranges found in diluted Peruvian propolis extracts.

Challenges and Mitigations

An unexpected challenge during the computational validation was managing the accelerated degradation rates of mRNA and proteins inherent to cell-free environments, which can severely weaken the predicted fluorescent signal. To overcome this limitation, proposed alternative strategies include modifying the digital plasmid design to incorporate highly stable structural RNA hairpins that would protect the transcripts from exonuclease activity. Another potential future problem is the loss of enzymatic activity during the physical lyophilization (freeze-drying) phase; to mitigate this, future laboratory optimizations will involve outlining test variations of lyoprotectants like sucrose or trehalose to find the optimal ratio that shields the molecular machinery during moisture removal.


SECTION 6: ADDITIONAL INFORMATION

References

  • Alguel, Y., Torรกn, W., et al. (2007). Crystal structure of TtgR, a central regulator of a multidrug efflux pump, bound to its specific plant ligands. Journal of Molecular Biology, 369(1), 305-316.
  • Terรกn, W., Krell, T., Ramos, J. L., & Gallegos, M. T. (2003). Efflux pump regulation by the TtgR repressor protein in Pseudomonas putida. Antimicrobial Agents and Chemotherapy, 47(10), 3067-3072.

Supply List and Budget

Equipment, Software, and Core Facility Services:

  • Benchling Academic Framework โ€” $0 USD (Free academic tier)
  • Asimov Kernel Workspace โ€” $0 USD (HTGAA academic license)
  • Autodock Vina / PyMOL Software Suite โ€” $0 USD (Open-source tools)
  • Opentrons OT-2 Platform Core Facility Fee โ€” $450 USD (Realistic allocation for automated instrument scheduling, cleanroom environment, and dedicated robotic filter tip boxes)
  • Institutional Lyophilizer / Freeze-Drying Runtime Service โ€” $250 USD (Facility fee covering deep-vacuum processing time, condenser cooling cycles, and technical assistance)

Consumables & Reagents (Proposed Future Budget):

  • Twist Biosciences Custom DNA Synthesis (Plasmid Assembly) โ€” $450 USD
  • Commercial Cell-Free Protein Expression Kit (e.g., NEB PUREXpress Kit, 10 rxns) โ€” $600 USD
  • High-Purity Lyoprotectants & Additives (Trehalose, Rehydration Salts, Matrix Buffers) โ€” $120 USD
  • Gibson Assembly Master Mix Reagents (NEB, Multi-reaction pack) โ€” $280 USD
  • Whatman No. 1 Chromatography Paper Sheets (For high-grade paper matrices) โ€” $60 USD
  • General Laboratory Molecular Consumables (RNase-free tubes, sterile storage vials) โ€” $140 USD
  • Total Proposed Project Budget: $2,350 USD